Development of a multi-target anticancer Sn(ii) pyridine-2-carboxaldehyde thiosemicarbazone complex

Dalton Trans. 2021 Aug 21;50(31):10909-10921. doi: 10.1039/d1dt01272j. Epub 2021 Jul 27.

Abstract

In this study, we proposed to design effective multi-target anticancer agents based on the chelation of nontoxic metals with ligands that possess anticancer activity. In total, five Sn(ii) pyridine-2-carboxaldehyde thiosemicarbazone complexes are synthesized and their activities are tested. Among these complexes, C5 is found to show the highest cytotoxicity on investigating their structure-activity relationships. In addition, C5 not only exhibits an effective inhibitory effect against tumor growth in vivo, but also suppresses angiogenesis and restricts the metastasis of cancer cells in vitro. Multiple mechanisms underlie the antitumor effect of C5, and they include acting against DNA, inducing apoptosis, and inhibiting the activities of anti-apoptotic Bcl-xL protein, metalloproteinase MMP2 and topoisomerase II.

MeSH terms

  • Antineoplastic Agents*
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Coordination Complexes
  • Drug Screening Assays, Antitumor
  • Humans
  • Thiosemicarbazones*

Substances

  • Antineoplastic Agents
  • Coordination Complexes
  • Thiosemicarbazones
  • 2-formylpyridine thiosemicarbazone